Employee compliance rises as medicine copays drop
Incorporating a value-based insurance design (VBID) can increase the use of important medications, according to a new study. The approach complements not only disease management programs but CDHPs as well. The study, led by a team of University of Michigan and Harvard University researchers and published in the January/February Health Affairs, showed that a large private employer significantly increased its employees' use of important chronic-disease medicines by making some free and reducing copays for others. Another employer that kept its copays the same (the control group) didn't experience the same increase.
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Handshaking Spreads Germs. Get Over It.
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts
- Healthcare Costs Start With What We Eat
- IOM Identifies GME Problems, Calls for Finance Changes
- Hospitals Likely to Outsource ICD-10 at Launch
- Revenue Cycles Get a Boost from Simple JPEG Files
- Anatomy of 3 Health System Rebranding Efforts
- Physicians to Appeal 'Docs v. Glocks' Ruling in FL